Reviewed by PillSeek Editorial Team · Last verified
Pill Identification
This is a Pink Oval pill with imprint 772;plain, identified as Idvynso doravirine 100 mg / islatravir 0.25 mg manufactured by Merck & Co., Inc. It is supplied as Chewable tablet and distributed under NDC 0006-5092-01.
⚠️ What to verify before taking this medication
- Verify the imprint, color, and shape match exactly — even a single different character can mean a different drug.
- Check the expiration date on the original packaging.
- Look for signs of tampering, discoloration, or unusual odor.
- Confirm with your pharmacist or prescriber before taking any medication you are unsure about.
- Never take medication prescribed to someone else.
This is patient-safety guidance, not medical advice. Read full medical disclaimer.
Pill Specs
- Imprint
- 772;plain
- Strength
- doravirine 100 mg / islatravir 0.25 mg
- Color
- Pink
- Dosage Form
- Chewable tablet
- Shape
- Oval
- Route
- Oral
- Size
- 17 mm
- DEA Schedule
- Schedule N/a
Medication Information
Read the official FDA Medication Guide — written for patients, sourced from DailyMed.
Read Medication GuideComposition
- Active Ingredients
- Doravirine and islatravir
- Inactive Ingredients
- Colloidal silicon dioxide, croscarmellose sodium, hypromellose acetate succinate, lactose monohydrate, magnesium stearate, microcrystalline cellulose. The tablet film coating contains calcium carbonate, ferric oxide, ferrosoferric oxide, hypromellose, lactose monohydrate, and triacetin. The coated tablets are polished with carnauba wax
Frequently Asked Questions
About this medication
- Manufacturer
- Merck & Co., Inc
- Status (Rx/OTC)
- Rx
- Brand Names
- Idvynso
- NDC Code
- 0006-5092-01
For educational use only. Always consult your pharmacist or doctor. Read disclaimer.